ID   CD22_MOUSE              Reviewed;         868 AA.
AC   P35329; Q3UP36; Q9JHL2; Q9JJX9; Q9JJY0; Q9JJY1; Q9R056; Q9R094; Q9WU51;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-FEB-2022, sequence version 2.
DT   03-AUG-2022, entry version 188.
DE   RecName: Full=B-cell receptor CD22 {ECO:0000305};
DE   AltName: Full=B-lymphocyte cell adhesion molecule;
DE            Short=BL-CAM;
DE   AltName: Full=Sialic acid-binding Ig-like lectin 2;
DE            Short=Siglec-2;
DE   AltName: Full=T-cell surface antigen Leu-14;
DE   AltName: CD_antigen=CD22;
DE   Flags: Precursor;
GN   Name=Cd22 {ECO:0000303|PubMed:10501843, ECO:0000312|MGI:MGI:88322};
GN   Synonyms=Lyb-8, Siglec2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-15; GLN-19; LYS-76;
RP   83-ALA--THR-86 DELINS LYS-ALA-GLU-PRO; 88-LYS--GLU-93 DEL; 96-LEU-SER-97
RP   DELINS PRO-PRO; ARG-100; SER-108; GLU-179; GLN-185 AND LYS-192; VAL-196;
RP   PRO-198; GLU-242; MET-793; ALA-796.
RC   STRAIN=DBA/2J; TISSUE=Liver;
RX   PubMed=8100843;
RA   Law C.-L., Torres R.M., Sundberg H.A., Parkhouse R.M., Brannan C.I.,
RA   Copeland N.G., Jenkins N.A., Clark E.A.;
RT   "Organization of the murine Cd22 locus. Mapping to chromosome 7 and
RT   characterization of two alleles.";
RL   J. Immunol. 151:175-187(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS LYS-76; 118-PRO--ARG-120 DELINS
RP   LEU-ILE-HIS; GLU-179; GLN-185; LYS-192; VAL-196; PRO-198; GLU-242; HIS-250;
RP   GLN-279; ILE-386; HIS-393; LEU-409; ARG-425; GLY-429; SER-488; LYS-554;
RP   ARG-626; ALA-796 AND THR-814.
RC   STRAIN=BXSB, C57BL/6J, and MRL/MpJ;
RX   PubMed=10501843; DOI=10.1007/s002510050584;
RA   Lajaunias F., Ibnou-Zekri N., Fossati Jimack L., Chicheportiche Y.,
RA   Parkhouse R.M., Mary C., Reininger L., Brighouse G., Izui S.;
RT   "Polymorphisms in the Cd22 gene of inbred mouse strains.";
RL   Immunogenetics 49:991-995(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Spleen;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-184 (ISOFORMS 1; 2 AND 3), AND VARIANTS
RP   ALA-15; GLN-19; LYS-76; 83-ALA--THR-86 DELINS LYS-ALA-GLU-PRO;
RP   83-ALA-THR-84 DELINS LYS-ALA; 85-LYS--PRO-90 DEL; 88-LYS--GLU-93 DEL;
RP   92-SER-GLU-93 DELINS PRO-GLY; 96-LEU-SER-97 DELINS PRO-PRO; ARG-100;
RP   SER-108 AND GLU-179.
RC   STRAIN=NZW/LacJ; TISSUE=Spleen;
RX   PubMed=10975807; DOI=10.4049/jimmunol.165.6.2987;
RA   Mary C., Laporte C., Parzy D., Santiago M.L., Stefani F., Lajaunias F.,
RA   Parkhouse M.E., O'Keefe T.L., Neuberger M.S., Izui S., Reininger L.;
RT   "Dysregulated expression of the Cd22 gene as a result of a short
RT   interspersed nucleotide element insertion in Cd22alpha lupus-prone mice.";
RL   J. Immunol. 165:2987-2996(2000).
RN   [6]
RP   SIALIC ACID-BINDING.
RX   PubMed=7533044; DOI=10.1016/s0960-9822(00)00220-7;
RA   Kelm S., Pelz A., Schauer R., Filbin M.T., Tang S., de Bellard M.E.,
RA   Schnaar R.L., Mahoney J.A., Hartnell A., Bradfield P., Crocker P.R.;
RT   "Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family
RT   of sialic acid-dependent adhesion molecules of the immunoglobulin
RT   superfamily.";
RL   Curr. Biol. 4:965-972(1994).
RN   [7]
RP   PHOSPHORYLATION BY LYN.
RX   PubMed=9601638; DOI=10.1016/s0960-9822(98)70223-4;
RA   Chan V.W., Lowell C.A., DeFranco A.L.;
RT   "Defective negative regulation of antigen receptor signaling in Lyn-
RT   deficient B lymphocytes.";
RL   Curr. Biol. 8:545-553(1998).
RN   [8]
RP   INTERACTION WITH GRB2; SYK; PIK3R1/PIK3R2 AND PLCG1, PHOSPHORYLATION AT
RP   TYR-783; TYR-828; TYR-843 AND TYR-863, AND MUTAGENESIS OF TYR-828.
RX   PubMed=10373493; DOI=10.1074/jbc.274.26.18769;
RA   Yohannan J., Wienands J., Coggeshall K.M., Justement L.B.;
RT   "Analysis of tyrosine phosphorylation-dependent interactions between
RT   stimulatory effector proteins and the B cell co-receptor CD22.";
RL   J. Biol. Chem. 274:18769-18776(1999).
RN   [9]
RP   INTERACTION WITH GRB2; SHC1 AND INPP5D, AND PHOSPHORYLATION BY LYN.
RX   PubMed=10748054; DOI=10.1074/jbc.m001892200;
RA   Poe J.C., Fujimoto M., Jansen P.J., Miller A.S., Tedder T.F.;
RT   "CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for
RT   regulation of B lymphocyte antigen receptor-induced calcium flux.";
RL   J. Biol. Chem. 275:17420-17427(2000).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-746; SER-747 AND SER-750, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Mediates B-cell B-cell interactions. May be involved in the
CC       localization of B-cells in lymphoid tissues. Binds sialylated
CC       glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-
CC       linked sialic acid. The sialic acid recognition site can be masked by
CC       cis interactions with sialic acids on the same cell surface. Upon
CC       ligand induced tyrosine phosphorylation in the immune response seems to
CC       be involved in regulation of B-cell antigen receptor signaling. Plays a
CC       role in positive regulation through interaction with Src family
CC       tyrosine kinases and may also act as an inhibitory receptor by
CC       recruiting cytoplasmic phosphatases via their SH2 domains that block
CC       signal transduction through dephosphorylation of signaling molecules.
CC   -!- SUBUNIT: Interacts with LYN, SYK, PIK3R1/PIK3R2, PLCG1, SHC1, INPP5D
CC       and GRB2 upon phosphorylation. May form a complex with INPP5D/SHIP,
CC       GRB2 and SHC1. Interacts with PTPN6/SHP-1 upon phosphorylation (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P35329; Q60631: Grb2; NbExp=4; IntAct=EBI-300059, EBI-1688;
CC       P35329; P29351: Ptpn6; NbExp=5; IntAct=EBI-300059, EBI-2620699;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=CD22-beta;
CC         IsoId=P35329-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35329-2; Sequence=VSP_002532;
CC       Name=3;
CC         IsoId=P35329-3; Sequence=VSP_002533;
CC   -!- TISSUE SPECIFICITY: B-lymphocytes.
CC   -!- DOMAIN: Contains 3 copies of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC   -!- PTM: Phosphorylated on tyrosine residues by LYN. {ECO:0000305}.
CC   -!- PTM: Phosphorylation of Tyr-783 and Tyr-843 are involved in binding to
CC       SYK. Phosphorylation of Tyr-828 is involved in binding to GRB2.
CC       Phosphorylation of Tyr-863 is involved in binding to SYK, PLCG2 and
CC       PIK3R1/PIK3R2. {ECO:0000269|PubMed:10373493}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. SIGLEC (sialic
CC       acid binding Ig-like lectin) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Siglec-2;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_mou_Itlect_194";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L16928; AAA02562.1; -; mRNA.
DR   EMBL; AF115401; AAD30392.1; -; mRNA.
DR   EMBL; AF115400; AAD30391.1; -; mRNA.
DR   EMBL; AF102134; AAF02417.1; -; mRNA.
DR   EMBL; AK143835; BAE25561.1; -; mRNA.
DR   EMBL; AC165340; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AJ250676; CAB85609.1; -; mRNA.
DR   EMBL; AJ250677; CAB85610.1; -; mRNA.
DR   EMBL; AJ250678; CAB85611.1; -; mRNA.
DR   EMBL; AJ250679; CAB85612.1; -; mRNA.
DR   EMBL; AJ250680; CAB85613.1; -; mRNA.
DR   EMBL; AJ250682; CAB85615.1; -; mRNA.
DR   EMBL; AJ250683; CAB85616.1; -; mRNA.
DR   CCDS; CCDS21114.1; -. [P35329-1]
DR   PIR; A46512; A46512.
DR   PIR; I49583; I49583.
DR   RefSeq; NP_001036782.1; NM_001043317.2.
DR   RefSeq; NP_033975.3; NM_009845.3.
DR   RefSeq; XP_006539556.1; XM_006539493.1.
DR   RefSeq; XP_006539557.1; XM_006539494.2.
DR   AlphaFoldDB; P35329; -.
DR   SMR; P35329; -.
DR   BioGRID; 198581; 8.
DR   CORUM; P35329; -.
DR   IntAct; P35329; 13.
DR   MINT; P35329; -.
DR   STRING; 10090.ENSMUSP00000019248; -.
DR   BindingDB; P35329; -.
DR   ChEMBL; CHEMBL1075279; -.
DR   GlyGen; P35329; 11 sites.
DR   iPTMnet; P35329; -.
DR   PhosphoSitePlus; P35329; -.
DR   jPOST; P35329; -.
DR   MaxQB; P35329; -.
DR   PaxDb; P35329; -.
DR   PRIDE; P35329; -.
DR   ProteomicsDB; 283740; -. [P35329-1]
DR   ProteomicsDB; 283741; -. [P35329-2]
DR   ProteomicsDB; 283742; -. [P35329-3]
DR   ProteomicsDB; 328745; -.
DR   Antibodypedia; 3714; 2402 antibodies from 56 providers.
DR   DNASU; 12483; -.
DR   Ensembl; ENSMUST00000019248; ENSMUSP00000019248; ENSMUSG00000030577. [P35329-1]
DR   Ensembl; ENSMUST00000108125; ENSMUSP00000103760; ENSMUSG00000030577. [P35329-1]
DR   Ensembl; ENSMUST00000186154; ENSMUSP00000139685; ENSMUSG00000030577. [P35329-1]
DR   Ensembl; ENSMUST00000189718; ENSMUSP00000140521; ENSMUSG00000030577. [P35329-1]
DR   Ensembl; ENSMUST00000190617; ENSMUSP00000139871; ENSMUSG00000030577. [P35329-1]
DR   GeneID; 12483; -.
DR   KEGG; mmu:12483; -.
DR   UCSC; uc009ggr.2; mouse.
DR   CTD; 933; -.
DR   MGI; MGI:88322; Cd22.
DR   VEuPathDB; HostDB:ENSMUSG00000030577; -.
DR   eggNOG; KOG4475; Eukaryota.
DR   GeneTree; ENSGT01050000244990; -.
DR   HOGENOM; CLU_017949_0_0_1; -.
DR   InParanoid; P35329; -.
DR   OMA; GCYICNA; -.
DR   OrthoDB; 54136at2759; -.
DR   PhylomeDB; P35329; -.
DR   TreeFam; TF334827; -.
DR   Reactome; R-MMU-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-MMU-5690714; CD22 mediated BCR regulation.
DR   Reactome; R-MMU-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   BioGRID-ORCS; 12483; 4 hits in 75 CRISPR screens.
DR   PRO; PR:P35329; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; P35329; protein.
DR   Bgee; ENSMUSG00000030577; Expressed in peripheral lymph node and 52 other tissues.
DR   GO; GO:0009986; C:cell surface; IDA:ARUK-UCL.
DR   GO; GO:0005769; C:early endosome; ISO:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IPI:MGI.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:ARUK-UCL.
DR   GO; GO:0055037; C:recycling endosome; ISO:MGI.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0042609; F:CD4 receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0015026; F:coreceptor activity; TAS:MGI.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:ARUK-UCL.
DR   GO; GO:0033691; F:sialic acid binding; IPI:ARUK-UCL.
DR   GO; GO:0042113; P:B cell activation; ISO:MGI.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:MGI.
DR   GO; GO:0050859; P:negative regulation of B cell receptor signaling pathway; ISO:MGI.
DR   GO; GO:0050849; P:negative regulation of calcium-mediated signaling; IGI:ARUK-UCL.
DR   GO; GO:0002638; P:negative regulation of immunoglobulin production; IGI:ARUK-UCL.
DR   GO; GO:0030888; P:regulation of B cell proliferation; IGI:ARUK-UCL.
DR   GO; GO:0030100; P:regulation of endocytosis; ISO:MGI.
DR   GO; GO:0050776; P:regulation of immune response; IGI:ARUK-UCL.
DR   Gene3D; 2.60.40.10; -; 6.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   Pfam; PF08205; C2-set_2; 1.
DR   Pfam; PF13895; Ig_2; 1.
DR   SMART; SM00409; IG; 7.
DR   SMART; SM00408; IGc2; 5.
DR   SUPFAM; SSF48726; SSF48726; 7.
DR   PROSITE; PS50835; IG_LIKE; 6.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Lectin; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..868
FT                   /note="B-cell receptor CD22"
FT                   /id="PRO_0000014874"
FT   TOPO_DOM        22..708
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        709..727
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        728..868
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          22..148
FT                   /note="Ig-like V-type"
FT   DOMAIN          153..250
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          257..347
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          352..435
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          440..521
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          526..603
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          614..697
FT                   /note="Ig-like C2-type 6"
FT   REGION          738..772
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          790..812
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           781..786
FT                   /note="ITIM motif 1"
FT   MOTIF           841..846
FT                   /note="ITIM motif 2"
FT   MOTIF           861..866
FT                   /note="ITIM motif 3"
FT   COMPBIAS        738..754
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        794..812
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         130
FT                   /ligand="N-acetylneuraminate"
FT                   /ligand_id="ChEBI:CHEBI:35418"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         746
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         747
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         750
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         783
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000305|PubMed:10373493"
FT   MOD_RES         828
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000305|PubMed:10373493"
FT   MOD_RES         843
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000305|PubMed:10373493"
FT   MOD_RES         863
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000305|PubMed:10373493"
FT   CARBOHYD        111
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        122
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        145
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        174
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        271
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        281
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        384
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        414
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        466
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        567
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        595
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        41..177
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        46..112
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        171..235
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        278..330
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        374..417
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        463..505
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        550..592
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        637..680
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         54..121
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10975807"
FT                   /id="VSP_002532"
FT   VAR_SEQ         106..139
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10975807"
FT                   /id="VSP_002533"
FT   VARIANT         15
FT                   /note="V -> A (in strain: DBA/2J and NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         19
FT                   /note="R -> Q (in strain: DBA/2J and NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         76
FT                   /note="T -> K (in strain: DBA/2J, BXSB and NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10501843,
FT                   ECO:0000269|PubMed:10975807, ECO:0000269|PubMed:8100843"
FT   VARIANT         83..86
FT                   /note="ATKT -> KAEP (in strain: DBA/2J and NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         83..84
FT                   /note="AT -> KA (in strain: NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807"
FT   VARIANT         85..90
FT                   /note="Missing (in strain: NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807"
FT   VARIANT         88..93
FT                   /note="Missing (in strain: DBA/2J and NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         92..93
FT                   /note="SE -> PG (in strain: NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807"
FT   VARIANT         96..97
FT                   /note="LS -> PP (in strain: DBA/2J and NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         100
FT                   /note="G -> R (in strain: DBA/2J and NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         108
FT                   /note="R -> S (in strain: DBA/2J and NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10975807,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         118..120
FT                   /note="PIR -> LIH (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         179
FT                   /note="G -> E (in strain: DBA/2J, BXSB and NZW/LacJ)"
FT                   /evidence="ECO:0000269|PubMed:10501843,
FT                   ECO:0000269|PubMed:10975807, ECO:0000269|PubMed:8100843"
FT   VARIANT         185
FT                   /note="K -> Q (in strain: DBA/2J and BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         192
FT                   /note="E -> K (in strain: DBA/2J and BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         196
FT                   /note="I -> V (in strain: DBA/2J and BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         198
FT                   /note="S -> P (in strain: DBA/2J and BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         242
FT                   /note="K -> E (in strain: DBA/2J and BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         250
FT                   /note="R -> H (in strain: MRL/MpJ)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         279
FT                   /note="R -> Q (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         386
FT                   /note="T -> I (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         393
FT                   /note="P -> H (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         409
FT                   /note="P -> L (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         425
FT                   /note="H -> R (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         429
FT                   /note="D -> G (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         488
FT                   /note="P -> S (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         554
FT                   /note="E -> K (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         626
FT                   /note="H -> R (in strain: BXSB)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   VARIANT         793
FT                   /note="T -> M (in strain: DBA/2J)"
FT                   /evidence="ECO:0000269|PubMed:8100843"
FT   VARIANT         796
FT                   /note="T -> A (in strain: DBA/2J; BXSB and MRL/MpJ)"
FT                   /evidence="ECO:0000269|PubMed:10501843,
FT                   ECO:0000269|PubMed:8100843"
FT   VARIANT         814
FT                   /note="S -> T (in strain: BXSB and MRL/MpJ)"
FT                   /evidence="ECO:0000269|PubMed:10501843"
FT   MUTAGEN         828
FT                   /note="Y->F: Abolishes binding to GRB2."
FT                   /evidence="ECO:0000269|PubMed:10373493"
SQ   SEQUENCE   868 AA;  97181 MW;  763991EE28747E7F CRC64;
     MRVHYLWLLL ILGHVASARY SSANDWTVDH PQTLFAWEGA CIRIPCKYKT PLPKARLDNI
     LLFQNYEFDK ATKKFTGTVL YNATKTEKDP ESELYLSKQG RVTFLGNRID NCTLKIHPIR
     ANDSGNLGLR MTAGTERWME PIHLNVSEKP FQPYIQMPSE IRESQSVTLT CGLNFSCFGY
     DILLKWFLED SEITSITSSV TSITSSVTSS IKNVYTESKL TFQPKWTDHG KSVKCQVQHS
     SKVLSERTVR LDVKYTPKLE IKVNPTEVEK NNSVTMTCRV NSSNPKLRTV AVSWFKDGRP
     LEDQELEQEQ QMSKLILHSV TKDMRGKYRC QASNDIGPGE SEEVELTVHY APEPSRVHIY
     PSPAEEGQSV ELICESLASP SATNYTWYHN RKPIPGDTQE KLRIPKVSPW HAGNYSCLAE
     NRLGHGKIDQ EAKLDVHYAP KAVTTVIQSF TPILEGDSVT LVCRYNSSNP DVTSYRWNPQ
     GSGSVLKPGV LRIQKVTWDS MPVSCAACNH KCSWALPVIL NVHYAPRDVK VLKVSPASEI
     RAGQRVLLQC DFAESNPAEV RFFWKKNGSL VQEGRYLSFG SVSPEDSGNY NCMVNNSIGE
     TLSQAWNLQV LYAPRRLRVS ISPGDHVMEG KKATLSCESD ANPPISQYTW FDSSGQDLHS
     SGQKLRLEPL EVQHTGSYRC KGTNGIGTGE SPPSTLTVYY SPETIGKRVA LGLGFCLTIC
     ILAIWGMKIQ KKWKQNRSQQ GLQENSSGQS FFVRNKKARR TPLSEGPQSQ GCYNPAMDDT
     VSYAILRFPE SDTHNTGDAG TPATQAPPPN NSDSVTYSVI QKRPMGDYEN VNPSCPEDES
     IHYSELVQFG AGKRPQAKED VDYVTLKH
//
